Convergent Genomics

📍 South San Francisco, United States🗓 Founded 2015👥 25 employees💰 Last funded Dec 2015
Biotechnology Research🌐 ConvergentGenomics.com
Website LinkedIn
Convergent Genomics is a precision medicine company that combines advances in genomics and machine learning to detect cancer early and non-invasively. Convergent is a leader in applying these technologies for use in liquid biopsy from urine. Using genomic data, our products further integrate clinical scenarios and scientific literature to richly contextualize a patient’s specific risk and enable unique data-driven decision-making. Our Mission: Transforming cancer care through clear and actionable insights.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Convergent Genomics?
Convergent Genomics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Convergent Genomics last raise funding?
The most recent investment in Convergent Genomics recorded on gritt.io was in December 2015.
When was Convergent Genomics founded?
Convergent Genomics was founded in 2015.
What industry is Convergent Genomics in?
Convergent Genomics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Convergent Genomics based?
Convergent Genomics is headquartered in South San Francisco, United States.